{"id":980417,"date":"2026-07-09T16:17:18","date_gmt":"2026-07-09T20:17:18","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/amneal-to-report-second-quarter-2026-results-on-july-30-2026\/"},"modified":"2026-07-09T16:17:18","modified_gmt":"2026-07-09T20:17:18","slug":"amneal-to-report-second-quarter-2026-results-on-july-30-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/amneal-to-report-second-quarter-2026-results-on-july-30-2026\/","title":{"rendered":"Amneal to Report Second Quarter 2026 Results on July 30, 2026"},"content":{"rendered":"<div class=\"mw_release\">\n<p>BRIDGEWATER, N.J., July  09, 2026  (GLOBE NEWSWIRE) &#8212; Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (\u201cAmneal\u201d or the \u201cCompany\u201d), today announced it will report second quarter 2026 financial results on Thursday, July 30, 2026, before market open. The Company will host an audio webcast at 8:30 a.m. ET.<\/p>\n<p>The financial results and live webcast will be available through the Investor Relations section of the Company&#8217;s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=gyPSBAUwulUPYy61KoJpmiqNNFsOKAmRL22X9hNEsqpZNlzFi4qLYJessp2mAomgvY0YcIMJeCgv0MT9owMsJTBQtFJpyvCl9c5PL7SkLS4=\" rel=\"nofollow\" target=\"_blank\">investors.amneal.com<\/a>. Individuals may register for the webcast by clicking <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=9j6KdC7fUYBk1RRP5puQB8HH8dzPMX2NYiNQof64AqQLZYzZXM5JSckTOYYeDhMWv7Ez4EYVyce_POu0GfDWy9c77ROSJr0ib-dDy6jzSZU=\" rel=\"nofollow\" target=\"_blank\">here<\/a>. To access the call by phone, dial 1 (833) 461-5787 (U.S.) or view a list of toll-free international numbers <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=9j6KdC7fUYBk1RRP5puQB9KXqHS2ygA6VfysB-bXT79sgiPV2agGH23O_auQuWspgWHV0ExJYVLxG9v-_M1WhkE-w8lglGjzhYmM947UCdShLnS49LoD6BGOrhF0_hsM\" rel=\"nofollow\" target=\"_blank\">here<\/a>. The access code for is 901153095. A replay of the webcast will be available shortly after the call.<\/p>\n<p>\n        <strong>About Amneal<\/strong><br \/>\n        <br \/>Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX), headquartered in Bridgewater, New Jersey, is a diversified, global biopharmaceutical leader focused on expanding access to affordable and innovative medicines. Founded in 2002 by brothers and co-CEOs Chirag and Chintu Patel, Amneal was built on the belief that innovation only matters if it\u2019s accessible. Today, Amneal has a diverse and growing portfolio of approximately 300 complex, specialty and biosimilar medicines, delivering over 160 million prescriptions each year, primarily in the United States. Our Affordable Medicines segment spans retail, injectable, and biosimilar products. Our Specialty segment provides branded treatments in neurology, including Parkinson\u2019s disease and migraine, and endocrinology. Our AvKARE segment distributes pharmaceuticals and medical products to U.S. federal, retail, and institutional customers. For more information, visit\u00a0\u00a0and follow us on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=y_CnUQr_EPSD9WYH9niXo_dhiZajks-DBuV-anW9d8boVk0z7kja5juHJ7UGMlclMLJC_RnbWfK-CEkgOoBhndKIJytqNje_76FptMV5u6VaIhO3OwhQULhwPRp_5tOw0W80ZQVIWKsarwT5cl1MZ0u-DvFk3QsK_cLRp0pnC3LXseNtLMnM5lHwYuDsEOOTn1YKcg5bnWRV5Gegy142l4JAHv22SJAwv1ytZcpkDMB-O5B9KtMnAywMCmpu8A8sbii9I7mFidi2wwG3cF4iY5yOvYgpA_pz1ItGTjzTjAu-0zqNmO-79l1WXXTj7l3Tb_qH22IZAJq9_tv-P8zmgpPpYZsAFkOWLb-KILBILlvb-qFUx31EANoNbhgkY_70K_A1fSqYqiL_dtxOeJzKY8FIrlPoW5j6Hh9JILfUZaDAHiSy83A0TAjJSIo8W9J0aUckzxt69gqqmXdt_jp0I3HhBbOaAx-URcZYBHJ7DdmwCPaBKG6LKnzqPPHLoHz4niwXDWYRzN9CdBWJvkPMAzi8XdsSQN2CC94wWTmNLmr1U-ogTNG7R9FaGH8btaDx9-tWnselJ7Og_R6_JBbOIqfnOfDds-hijVjuciLgT5lR-LaQh_9kXqQAmZEJYLlaHt3JRbO7GX3-9Fp1JqNmmPXbdvYAu57o4R7CszA9DeLYDI3KG5cSTw-SajlzX9cFI3BsgPwZ30nNwBls717aOznVmxJmFur7u5fXndqAM0rSKR6Y4YDYPLKNsCtnR0N6\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p>\n        <strong>Investor Contact <\/strong><br \/>\n        <br \/>Anthony DiMeo<br \/>VP, Investor Relations<br \/>anthony.dimeo@amneal.com<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1OTg0OCM3Njk5Mjc4IzIxOTA3Mzc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZjY0MDEzZjUtMTFiZi00NTliLTk0ZDQtMmQ0NGEyYTg5MDUyLTEyMDIyOTAtMjAyNi0wNy0wOS1lbg==\/tiny\/Amneal-Pharmaceuticals-LLC.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BRIDGEWATER, N.J., July 09, 2026 (GLOBE NEWSWIRE) &#8212; Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (\u201cAmneal\u201d or the \u201cCompany\u201d), today announced it will report second quarter 2026 financial results on Thursday, July 30, 2026, before market open. The Company will host an audio webcast at 8:30 a.m. ET. The financial results and live webcast will be available through the Investor Relations section of the Company&#8217;s website at investors.amneal.com. Individuals may register for the webcast by clicking here. To access the call by phone, dial 1 (833) 461-5787 (U.S.) or view a list of toll-free international numbers here. The access code for is 901153095. A replay of the webcast will be available shortly after the call. About Amneal Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX), &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/amneal-to-report-second-quarter-2026-results-on-july-30-2026\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Amneal to Report Second Quarter 2026 Results on July 30, 2026&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-980417","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Amneal to Report Second Quarter 2026 Results on July 30, 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/amneal-to-report-second-quarter-2026-results-on-july-30-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Amneal to Report Second Quarter 2026 Results on July 30, 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BRIDGEWATER, N.J., July 09, 2026 (GLOBE NEWSWIRE) &#8212; Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (\u201cAmneal\u201d or the \u201cCompany\u201d), today announced it will report second quarter 2026 financial results on Thursday, July 30, 2026, before market open. The Company will host an audio webcast at 8:30 a.m. ET. The financial results and live webcast will be available through the Investor Relations section of the Company&#8217;s website at investors.amneal.com. Individuals may register for the webcast by clicking here. To access the call by phone, dial 1 (833) 461-5787 (U.S.) or view a list of toll-free international numbers here. The access code for is 901153095. A replay of the webcast will be available shortly after the call. About Amneal Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX), &hellip; Continue reading &quot;Amneal to Report Second Quarter 2026 Results on July 30, 2026&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/amneal-to-report-second-quarter-2026-results-on-july-30-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-09T20:17:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1OTg0OCM3Njk5Mjc4IzIxOTA3Mzc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/amneal-to-report-second-quarter-2026-results-on-july-30-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/amneal-to-report-second-quarter-2026-results-on-july-30-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Amneal to Report Second Quarter 2026 Results on July 30, 2026\",\"datePublished\":\"2026-07-09T20:17:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/amneal-to-report-second-quarter-2026-results-on-july-30-2026\\\/\"},\"wordCount\":254,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/amneal-to-report-second-quarter-2026-results-on-july-30-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc1OTg0OCM3Njk5Mjc4IzIxOTA3Mzc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/amneal-to-report-second-quarter-2026-results-on-july-30-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/amneal-to-report-second-quarter-2026-results-on-july-30-2026\\\/\",\"name\":\"Amneal to Report Second Quarter 2026 Results on July 30, 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/amneal-to-report-second-quarter-2026-results-on-july-30-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/amneal-to-report-second-quarter-2026-results-on-july-30-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc1OTg0OCM3Njk5Mjc4IzIxOTA3Mzc=\",\"datePublished\":\"2026-07-09T20:17:18+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/amneal-to-report-second-quarter-2026-results-on-july-30-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/amneal-to-report-second-quarter-2026-results-on-july-30-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/amneal-to-report-second-quarter-2026-results-on-july-30-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc1OTg0OCM3Njk5Mjc4IzIxOTA3Mzc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc1OTg0OCM3Njk5Mjc4IzIxOTA3Mzc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/amneal-to-report-second-quarter-2026-results-on-july-30-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Amneal to Report Second Quarter 2026 Results on July 30, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Amneal to Report Second Quarter 2026 Results on July 30, 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/amneal-to-report-second-quarter-2026-results-on-july-30-2026\/","og_locale":"en_US","og_type":"article","og_title":"Amneal to Report Second Quarter 2026 Results on July 30, 2026 - Market Newsdesk","og_description":"BRIDGEWATER, N.J., July 09, 2026 (GLOBE NEWSWIRE) &#8212; Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (\u201cAmneal\u201d or the \u201cCompany\u201d), today announced it will report second quarter 2026 financial results on Thursday, July 30, 2026, before market open. The Company will host an audio webcast at 8:30 a.m. ET. The financial results and live webcast will be available through the Investor Relations section of the Company&#8217;s website at investors.amneal.com. Individuals may register for the webcast by clicking here. To access the call by phone, dial 1 (833) 461-5787 (U.S.) or view a list of toll-free international numbers here. The access code for is 901153095. A replay of the webcast will be available shortly after the call. About Amneal Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX), &hellip; Continue reading \"Amneal to Report Second Quarter 2026 Results on July 30, 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/amneal-to-report-second-quarter-2026-results-on-july-30-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-07-09T20:17:18+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1OTg0OCM3Njk5Mjc4IzIxOTA3Mzc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/amneal-to-report-second-quarter-2026-results-on-july-30-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/amneal-to-report-second-quarter-2026-results-on-july-30-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Amneal to Report Second Quarter 2026 Results on July 30, 2026","datePublished":"2026-07-09T20:17:18+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/amneal-to-report-second-quarter-2026-results-on-july-30-2026\/"},"wordCount":254,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/amneal-to-report-second-quarter-2026-results-on-july-30-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1OTg0OCM3Njk5Mjc4IzIxOTA3Mzc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/amneal-to-report-second-quarter-2026-results-on-july-30-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/amneal-to-report-second-quarter-2026-results-on-july-30-2026\/","name":"Amneal to Report Second Quarter 2026 Results on July 30, 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/amneal-to-report-second-quarter-2026-results-on-july-30-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/amneal-to-report-second-quarter-2026-results-on-july-30-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1OTg0OCM3Njk5Mjc4IzIxOTA3Mzc=","datePublished":"2026-07-09T20:17:18+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/amneal-to-report-second-quarter-2026-results-on-july-30-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/amneal-to-report-second-quarter-2026-results-on-july-30-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/amneal-to-report-second-quarter-2026-results-on-july-30-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1OTg0OCM3Njk5Mjc4IzIxOTA3Mzc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc1OTg0OCM3Njk5Mjc4IzIxOTA3Mzc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/amneal-to-report-second-quarter-2026-results-on-july-30-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Amneal to Report Second Quarter 2026 Results on July 30, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/980417","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=980417"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/980417\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=980417"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=980417"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=980417"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}